X4 Pharmaceuticals annual meeting elects directors, ratifies auditor, approves say-on-pay

X4 Pharmaceuticals, Inc

Stockholders elected David McGirr, Paula Ragan, and Michael S. Wzyga as directors for three-year terms.
Ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2024 passed with 129,116,244 for, 620,394 against.
Non-binding say-on-pay vote approved with 89,159,259 for, 4,443,024 against, and 36,561,395 broker non-votes.
All three proposals received requisite majority support; no other matters were submitted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.